Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.

[1]  J. Encke,et al.  Pharmacologic cholinesterase inhibition improves survival in experimental sepsis* , 2008, Critical care medicine.

[2]  V. Pavlov,et al.  Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis * , 2007, Critical care medicine.

[3]  V. Pavlov,et al.  Neuro-immune interactions via the cholinergic anti-inflammatory pathway. , 2007, Life sciences.

[4]  T. van der Poll,et al.  STIMULATION OF &agr;7 CHOLINERGIC RECEPTORS INHIBITS LIPOPOLYSACCHARIDE-INDUCED NEUTROPHIL RECRUITMENT BY A TUMOR NECROSIS FACTOR &agr;-INDEPENDENT MECHANISM , 2007, Shock.

[5]  S. Calvano,et al.  Nicotine exposure alters in vivo human responses to endotoxin , 2006, Clinical and experimental immunology.

[6]  V. Pavlov,et al.  Controlling inflammation: the cholinergic anti-inflammatory pathway. , 2006, Biochemical Society transactions.

[7]  P. Fırat,et al.  Effect of Neostigmine on Organ Injury in Murine Endotoxemia: Missing Facts about the Cholinergic Antiinflammatory Pathway , 2005, World Journal of Surgery.

[8]  T. van der Poll,et al.  The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. , 2005, The Journal of infectious diseases.

[9]  K. Tracey,et al.  Autonomic neural regulation of immunity , 2005, Journal of internal medicine.

[10]  J. Andersson,et al.  The inflammatory reflex – Introduction , 2005, Journal of internal medicine.

[11]  K. Tracey,et al.  Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.